Market Place
Sourcing Support
Medisca Statement on Settlement With Department of Justice
01 Nov 2024 //
BUSINESSWIRE
Enforcement Report - Week of July 10, 2024
10 Jul 2024 //
FDA
Medisca Opens New Facility to Meet Personalized Medicine Demand
27 Jun 2024 //
BUSINESSWIRE
Medisca Appoints Sanjay D. Goorachurn As CEO
16 Apr 2024 //
BUSINESSWIRE
Medisca Opens MAZ® Lab in Arizona: An Innovation and Customer Resource Center
26 Mar 2024 //
BUSINESSWIRE
Medisca Takes Steps to Protect its Innovative Technologies
26 Sep 2023 //
BUSINESSWIRE
Medisca Celebrates 5-Year Partnership to Resources for Chronic Pain Management
29 Aug 2023 //
BUSINESSWIRE
Medisca Expands Partnerships to Drive Patient Access to Critical Medications
27 Jul 2023 //
BUSINESSWIRE
Medisca to Open New Plattsburgh, NY Facility Exceeding Rigorous Quality
27 Oct 2022 //
BUSINESSWIRE
Medisca Unveils New Brand Identity and Corporate Positioning
22 Aug 2022 //
BUSINESSWIRE
Medisca Acquires all IP assets of Maxima Pharmaceuticals
28 Jun 2022 //
BUSINESSWIRE
Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA
27 May 2022 //
PRESS RELEASE
MEDISCA for Revisions to Compounded Expiry Dates and Succeed
12 Aug 2021 //
BUSINESSWIRE
MEDISCA Signs Distribution Agreement for FLAVORx Flavours in the Canadian Market
29 Jun 2018 //
BUSINESSWIRE
Enforcement Report - Week of September 27, 2017
28 Sep 2017 //
FDA
Medisca Inc recalls CITRULLINE(L) lot due to Label Mix-Up
24 Feb 2016 //
FDA
Medisca Inc. receives FDA warning letter
08 Dec 2015 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.